Roy Harper

11.1k citations
45 papers · 9.0k · 4 hit papers · h-index 18

Impact in

Papers in

Roy Harper

45 papers receiving 8.5k citations

Roy Harper's Hit Papers

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial 2019 · 492 citations
4920+9+18Years since publication10002.0k3.0k4.0k

Peers

Roy Harper
Comparison fields: 5 of 133
  • Endocrinology, Diabetes and Metabolism 4.6k
  • Cardiology and Cardiovascular Medicine 2.5k
  • Nephrology 595
  • Ophthalmology 582
  • Pharmacology 803
Replace Ian Peacock with:
Ian Peacock United Kingdom
M. Charlton United Kingdom
Shawna D. Nesbitt United States
Beryl A. Barrow United Kingdom
D. R. Hadden United Kingdom
Sanjoy Ketan Paul Australia
M S Hammersley United Kingdom
Richard Paisey United Kingdom
Björn Eliasson Sweden
Soffia Guðbjörnsdóttir Sweden
Roy Harper relative to Ian Peacock United Kingdom Ian Peacock's profile →
Citations per field
00.5×5×10×15×20×24.6×
Ian Peacock · 1×
Citations per year

Countries citing papers authored by Roy Harper

Since Specialization
Citations

This map shows the geographic impact of Roy Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Harper more than expected).

Fields of papers citing papers by Roy Harper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Harper. The network helps show where Roy Harper may publish in the future.

Co-authors

The 25 scholars most cited alongside Roy Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roy Harper Line = papers co-authored together Roy Harper links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
Hit paper breakdown →
19984201
2
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20192307
3
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
Hit paper breakdown →
19981201
4
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hit paper breakdown →
2019492
5 2007140
6 201680
7 199776
8 201045
9 201240
10 199830
11 200128
12 201228
13 201027
14 200826
15 200523
16 201422
17 201820
18 200420
19 200617
20 201716

About Roy Harper

Roy Harper is a scholar working on Endocrinology, Diabetes and Metabolism, Health Information Management, Obstetrics and Gynecology, General Health Professions and Organizational Behavior and Human Resource Management, having authored 45 papers that have together received 9.0k indexed citations. Recurring topics across this work include Gestational Diabetes Research and Management (8 papers), Diabetes Management and Research (8 papers), Diabetes Treatment and Management (7 papers), Artificial Intelligence in Healthcare (6 papers), Diabetes Management and Education (6 papers), Mobile Health and mHealth Applications (6 papers), Data Mining Algorithms and Applications (4 papers) and Healthcare Systems and Technology (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.6k citations), Cardiology and Cardiovascular Medicine (2.5k citations), Nephrology (595 citations), Ophthalmology (582 citations) and Pharmacology (803 citations). Roy Harper has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Norman D. Black, Paul J. McCullagh, Yue Huang, Valerie A Holmes, Fiona A. Alderdice, David R. McCance, Patrick M Bell, A. Brew Atkinson, Michael McTear and Oonagh McSorley. Their work appears in journals such as Diabetes Technology & Therapeutics, Journal of Telemedicine and Telecare, The Lancet, Journal of Hypertension and Diabetic Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact